For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Cancer resistance to chemotherapy is a major barrier to successful treatment. Resistance is often caused by proteins such as multidrug resistance-associated proteins (MRPs) and P glycoproteins that pump chemotherapy agents from cells, but also occurs due to secondary mutations in drug targets or effectors. Use this page to find out more.